Literature DB >> 24021517

Impact of physiologic estrogen replacement on anxiety symptoms, body shape perception, and eating attitudes in adolescent girls with anorexia nervosa: data from a randomized controlled trial.

Madhusmita Misra1, Debra K Katzman, Nara Mendes Estella, Kamryn T Eddy, Thomas Weigel, Mark A Goldstein, Karen K Miller, Anne Klibanski.   

Abstract

OBJECTIVE: Anorexia nervosa is characterized by low weight, aberrant eating attitudes, body image distortion, and hypogonadism. Anxiety is a common comorbid condition. Estrogen replacement reduces anxiety in animal models, and reported variations in food intake across the menstrual cycle may be related to gonadal steroid levels. The impact of estrogen replacement on anxiety, eating attitudes, and body image has not been reported in anorexia nervosa. We hypothesized that physiologic estrogen replacement would ameliorate anxiety and improve eating attitudes without affecting body image in anorexia nervosa.
METHOD: Girls 13-18 years old with anorexia nervosa (DSM-IV) were randomized to transdermal estradiol (100 μg twice weekly) with cyclic progesterone or placebo patches and pills for 18-months, between 2002 and 2010. The State-Trait Anxiety Inventory for Children (STAIC), the Eating Disorders Inventory-2 (EDI-2), and the Body Shape Questionnaire (BSQ-34) were administered. 72 girls completed these measures at baseline (n=38 [girls receiving estrogen] and n=34 [girls receiving placebo]) and 37 at 18 months (n=20 [girls receiving estrogen] and n=17 [girls receiving placebo]). The primary outcome measure was the change in these scores over 18 months.
RESULTS: Estrogen replacement caused a decrease in STAIC-trait scores (-3.05 [1.22] vs. 2.07 [1.73], P=.02), without impacting STAIC-state scores (-1.11 [2.17] vs. 0.20 [1.42], P=.64). There was no effect of estrogen replacement on EDI-2 or BSQ-34 scores. Body mass index (BMI) changes did not differ between groups, and effects of estrogen replacement on STAIC-trait scores persisted after controlling for BMI changes (P=.03). Increases in serum estradiol were significantly associated with decreases in STAIC-trait scores (Spearman ρ = -0.45, P=.03).
CONCLUSIONS: Estrogen replacement improved trait anxiety (the tendency to experience anxiety) but did not impact eating attitudes or body shape perception. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT00088153. © Copyright 2013 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24021517      PMCID: PMC4017248          DOI: 10.4088/JCP.13m08365

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  21 in total

1.  Menstrual cycle and voluntary food intake in young Chinese women.

Authors:  E T Li; L B Tsang; S S Lui
Journal:  Appetite       Date:  1999-08       Impact factor: 3.868

2.  Effects of the estrous cycle and ovarian hormones on behavioral indices of anxiety in female rats.

Authors:  S Mora; N Dussaubat; G Díaz-Véliz
Journal:  Psychoneuroendocrinology       Date:  1996-10       Impact factor: 4.905

3.  Current and lifetime psychiatric illness in women with Turner syndrome.

Authors:  Graca Cardoso; Robert Daly; Nazli A Haq; Lori Hanton; David R Rubinow; Carolyn A Bondy; Peter Schmidt
Journal:  Gynecol Endocrinol       Date:  2004-12       Impact factor: 2.260

4.  Emotional intelligence in anorexia nervosa: is anxiety a missing piece of the puzzle?

Authors:  David Hambrook; Gary Brown; Kate Tchanturia
Journal:  Psychiatry Res       Date:  2012-06-15       Impact factor: 3.222

5.  Comorbidity of anxiety disorders with anorexia and bulimia nervosa.

Authors:  Walter H Kaye; Cynthia M Bulik; Laura Thornton; Nicole Barbarich; Kim Masters
Journal:  Am J Psychiatry       Date:  2004-12       Impact factor: 18.112

Review 6.  Psychopathology in women and men: focus on female hormones.

Authors:  M V Seeman
Journal:  Am J Psychiatry       Date:  1997-12       Impact factor: 18.112

7.  Effects of anorexia nervosa on clinical, hematologic, biochemical, and bone density parameters in community-dwelling adolescent girls.

Authors:  Madhusmita Misra; Avichal Aggarwal; Karen K Miller; Cecilia Almazan; Megan Worley; Leslie A Soyka; David B Herzog; Anne Klibanski
Journal:  Pediatrics       Date:  2004-12       Impact factor: 7.124

8.  Abnormal bone mineral accrual in adolescent girls with anorexia nervosa.

Authors:  Leslie A Soyka; Madhusmita Misra; Aparna Frenchman; Karen K Miller; Steven Grinspoon; David A Schoenfeld; Anne Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2002-09       Impact factor: 5.958

9.  Estrogen alters behavior and forebrain c-fos expression in ovariectomized rats subjected to the forced swim test.

Authors:  I M Rachman; J R Unnerstall; D W Pfaff; R S Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

10.  Novel actions of estrogen receptor-beta on anxiety-related behaviors.

Authors:  Trent D Lund; Tomislav Rovis; Wilson C J Chung; Robert J Handa
Journal:  Endocrinology       Date:  2004-10-28       Impact factor: 4.736

View more
  20 in total

Review 1.  Neuroendocrinology of reward in anorexia nervosa and bulimia nervosa: Beyond leptin and ghrelin.

Authors:  Laura A Berner; Tiffany A Brown; Jason M Lavender; Emily Lopez; Christina E Wierenga; Walter H Kaye
Journal:  Mol Cell Endocrinol       Date:  2018-11-02       Impact factor: 4.102

Review 2.  The Role of Psychotropic Medications in the Management of Anorexia Nervosa: Rationale, Evidence and Future Prospects.

Authors:  Guido K W Frank; Megan E Shott
Journal:  CNS Drugs       Date:  2016-05       Impact factor: 5.749

Review 3.  The endocrine manifestations of anorexia nervosa: mechanisms and management.

Authors:  Melanie Schorr; Karen K Miller
Journal:  Nat Rev Endocrinol       Date:  2016-11-04       Impact factor: 43.330

Review 4.  Pharmacotherapy of eating disorders.

Authors:  Haley Davis; Evelyn Attia
Journal:  Curr Opin Psychiatry       Date:  2017-11       Impact factor: 4.741

Review 5.  Endocrine consequences of anorexia nervosa.

Authors:  Madhusmita Misra; Anne Klibanski
Journal:  Lancet Diabetes Endocrinol       Date:  2014-04-02       Impact factor: 32.069

6.  Sex differences in circuits activated by corticotropin releasing factor in rats.

Authors:  Madeleine Salvatore; Kimberly R Wiersielis; Sandra Luz; David E Waxler; Seema Bhatnagar; Debra A Bangasser
Journal:  Horm Behav       Date:  2017-12-14       Impact factor: 3.587

7.  Estrogen administration improves the trajectory of eating disorder pathology in oligo-amenorrheic athletes: A randomized controlled trial.

Authors:  Franziska Plessow; Vibha Singhal; Alexander T Toth; Nadia Micali; Kamryn T Eddy; Madhusmita Misra
Journal:  Psychoneuroendocrinology       Date:  2018-11-16       Impact factor: 4.905

Review 8.  Anorexia Nervosa and Its Associated Endocrinopathy in Young People.

Authors:  Madhusmita Misra; Anne Klibanski
Journal:  Horm Res Paediatr       Date:  2016-02-11       Impact factor: 2.852

Review 9.  Psychopharmacologic treatment of eating disorders: emerging findings.

Authors:  Susan L McElroy; Anna I Guerdjikova; Nicole Mori; Paul E Keck
Journal:  Curr Psychiatry Rep       Date:  2015-05       Impact factor: 5.285

10.  Exogenous progesterone exacerbates running response of adolescent female mice to repeated food restriction stress by changing α4-GABAA receptor activity of hippocampal pyramidal cells.

Authors:  G S Wable; Y-W Chen; S Rashid; C Aoki
Journal:  Neuroscience       Date:  2015-09-14       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.